TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 138 resultados LastUpdate Última actualización 21/07/2019 [16:35:00] pdf PDF

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days

Página1 de 6 nextPage   por página


METHOD AND SYSTEM FOR DETERMINING A CARBOHYDRATE INTAKE EVENT FROM GLUCOSE MONITORING DATA INDICATIVE OF A GLUCOSE LEVEL, AND A NON-TRANSITORY COMPUTER READABLE MEDIUM

NºPublicación: US2019216405A1 18/07/2019

Solicitante:

ROCHE DIABETES CARE INC [US]

CN_109788911_A

Resumen de: US2019216405A1

The disclosure relates to a method and a system for determining a carbohydrate intake event from glucose monitoring data indicative of a glucose level in a system having a data processing device provided with one or more processors. The method comprises steps of: receiving a glucose monitoring value by the data processing device, the glucose monitoring value indicating a glucose level sampled from a person in a bodily fluid in a glucose level measurement; receiving, by the data processing device, insulin bolus administration data indicating an insulin bolus of an insulin bolus administration; determining, by the data processing device, from an analysis of the glucose monitoring value, a carbohydrate intake event if one of the following is detected: the glucose monitoring value indicates a glucose level below a first threshold glucose level; and the glucose monitoring value indicates an elevated glucose level above a second threshold glucose level, and the insulin bolus indicated by the insulin bolus administration data is exceeding a corrective insulin bolus suitable for compensating for the elevated glucose level; and generating, by the data processing device, carbohydrate intake event data indicating the determined carbohydrate intake event. Further, a non-transitory computer readable medium is provided.

traducir

USER INTERFACE FOR DIABETES MANAGEMENT SYSTEM

NºPublicación: US2019221307A1 18/07/2019

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2017199985_PA

Resumen de: US2019221307A1

A diabetes management system including a pump for dispensing a medicant and a control device for controlling the pump includes a user interface for controlling functions of the pump and providing information related to operation of the pump and other information. The user interface can display blood glucose information and insulin dosing data such that a user can appropriately act on the information and/or gain confidence that the diabetes management system is operating appropriately to manage the disease. User interfaces provided herein can include displays of current and projected glucose values, bolus calculators, charts displaying glucose levels and/or insulin delivery data, system maintenance reminders, system status information, patient configuration input screens, and log-in screens. Diabetes management systems can include insulin pumps, continuous glucose monitors, blood glucose monitors, mobile computing devices, servers, and/or other insulin delivery devices (e.g., insulin pens).

traducir

NON-INVASIVE BLOOD SUGAR LEVEL MONITORING APPARATUS INTEGRATED WITH REAL-TIME HEALTH SUPPORT SYSTEM

NºPublicación: WO2019138382A1 18/07/2019

Solicitante:

GOPALAKRISHNAN MURALIDHARAN [IN]

Resumen de: WO2019138382A1

A non-invasive continuous blood sugar level monitoring apparatus integrated with real-time health support system. The blood sugar levels and other vital physiological information of the user can also be tracked wirelessly through the apparatus. The apparatus has an integrated real-time alert and reminder feature for notifying the user during medication and unusual physiological conditions. An automated diet and lifestyle recommendation solution is integrated into the device to help the user maintain healthy blood sugar and blood pressure levels. The low-powered telemetry device is used for communicating the stored physiological information of the user and the computed results between the network of devices.

traducir

NON-INVASIVE BLOOD SUGAR LEVEL MONITORING APPARATUS INTEGRATED WITH REAL-TIME HEALTH SUPPORT SYSTEM

NºPublicación: WO2019138381A1 18/07/2019

Solicitante:

GOPALAKRISHNAN MURALIDHARAN [IN]

Resumen de: WO2019138381A1

A non-invasive continuous blood sugar level monitoring apparatus integrated with a real-time health support system. The blood sugar levels and other vital physiological information of the user can also be tracked wirelessly through the apparatus. The apparatus has an integrated real-time alert and reminder feature for notifying the user during medication and unusual physiological conditions. An automated diet and lifestyle recommendation solution is integrated into the device to help the user maintain healthy blood sugar and blood pressure levels. The low-powered the telemetry device is used for communicating the stored physiological information of the user and the computed results between the network of devices.

traducir

COMPONENT MEASUREMENT SYSTEM, MEASUREMENT DEVICE, AND MEASUREMENT TIP

NºPublicación: WO2019138681A1 18/07/2019

Solicitante:

TERUMO CORP [JP]

Resumen de: WO2019138681A1

This component measurement system (10) comprises a measurement tip (12) capable of collecting blood and a measurement device (14) for measuring the blood glucose level of the blood collected by the measurement tip (12). The measurement tip (12) has, on the surface of the tip body (16), a printing layer (18) indicating information about a clearance (CL). The measurement device (14) has a reading unit (96) for reading the information about the clearance (CL) from the printing layer (18) and a control unit (88) for calculating a blood glucose level on the basis of the clearance (CL) read by the reading unit (96).

traducir

ELECTRONIC DEVICE AND ESTIMATION SYSTEM

NºPublicación: US2019216337A1 18/07/2019

Solicitante:

KYOCERA CORP [JP]

JP_WO2018003491_A1

Resumen de: US2019216337A1

An electronic device includes a sensor configured to acquire a subject's pulse wave, a blood pressure measurement portion configured to measure the subject's blood pressure level, and a controller configured to estimate a state of glucose metabolism or lipid metabolism of the subject on the basis of an index based on the subject's pulse wave acquired by the sensor and the subject's blood pressure level measured by the blood pressure measurement portion.

traducir

APPARATUS AND METHOD FOR CREATING A STABLE OPTICAL INTERFACE

NºPublicación: US2019216370A1 18/07/2019

Solicitante:

MASIMO CORP [US]

US_2018249933_A1

Resumen de: US2019216370A1

A system and a method for creating a stable and reproducible interface of an optical sensor system for measuring blood glucose levels in biological tissue include a dual wedge prism sensor attached to a disposable optic that comprises a focusing lens and an optical window. The disposable optic adheres to the skin to allow a patient to take multiple readings or scans at the same location. The disposable optic includes a Petzval surface placed flush against the skin to maintain the focal point of the optical beam on the surface of the skin. Additionally, the integrity of the sensor signal is maximized by varying the rotation rates of the dual wedge prisms over time in relation to the depth scan rate of the sensor. Optimally, a medium may be injected between the disposable and the skin to match the respective refractive indices and optimize the signal collection of the sensor.

traducir

PERSONAL DIGITAL ASSISTANT OR ORGANIZER FOR MONITORING GLUCOSE LEVELS

NºPublicación: US2019216319A1 18/07/2019

Solicitante:

CERCACOR LABORATORIES INC [US]

US_2011082711_PA

Resumen de: US2019216319A1

The present disclosure provides an electronic device that includes at least one sensor indicative of a physiological condition of a user, the at least one sensor worn by a patient. The electronic device can further include a location determination module configured to determine a location of a patient. The electronic device can receive a measured information from the sensor and determine if the physiological condition of the user indicates an urgent medical need. When the physiological condition of the user indicates an urgent medical need, the electronic device can contact emergency services and access and contact one or more of a contact in an electronic address book associated with the processing system. The electronic device can provide a location of the user based on information determined by the location determination module.

traducir

LIQUID MEDICINE INJECTION DEVICE

NºPublicación: EP3511037A1 17/07/2019

Solicitante:

EOFLOW CO LTD [KR]

US_2019192765_A1

Resumen de: EP3511037A1

The present invention discloses a liquid medicine injection device that is attached to a patient's body to inject liquid medicine such as insulin at an appropriate time.A liquid medicine injection device according to the present invention includes: a case; a liquid medicine tank that is disposed in the case and where liquid medicine is received; an electro-osmosis pump that is connected with the liquid medicine tank and moves the liquid medicine; a needle assembly that receives the liquid medicine by being connected to the electro-osmosis pump and injects the received liquid medicine into a human body; and an adhesive member combined to the case and attached to the human body.

traducir

EXTERNAL COUNTERPULSATION SYSTEM

NºPublicación: WO2019136429A1 11/07/2019

Solicitante:

POON MICHAEL [US]

Resumen de: WO2019136429A1

Improved systems and methods for performing external counterpulsation (ECP) treatment are described. The system can be more compact and portable than conventional devices and, in some cases, can be incorporated into a pair of pants or a jumpsuit, such that the user can remain ambulatory during treatment. In various instances, the ECP techniques can include applying complex pulse sequences and treating conditions including cognitive disorders, diabetes, and renal disease, among others. The various techniques can also be used in emergency cardiac situations. The techniques can also be used to provide users with the benefits of exercise, without needing to experience the strain and difficulty associated with conventional cardiovascular exercise routines.

traducir

APPARATUS AND METHODS FOR ANALYTE SENSOR MISMATCH CORRECTION

NºPublicación: US2019212323A1 11/07/2019

Solicitante:

GLYSENS INCORPORATED [US]

WO_2019135988_A1

Resumen de: US2019212323A1

Apparatus and methods for response modeling and correction of signals associated with a parameter sensor. In one exemplary embodiment, the parameter sensor is configured to measure a physiologic analyte of a living being (e.g., blood glucose), and the apparatus and methods employ a mathematical transformation of two or more sensing elements (electrodes) of the sensor in order to compensate for temporal response differences or “mismatch.” This compensation enables the calculated blood analyte level, which results from processing of the signals of the two or more sensing electrodes, to be more accurate than calculations made without such compensation. In one variant, the parameter signals are generated, and compensation processing conducted, autonomously via a common implanted sensor platform.

traducir

SYSTEMS AND METHODS FOR INTERACTIVE EXERCISE THERAPY

NºPublicación: WO2019136400A2 11/07/2019

Solicitante:

FITSCRIPT LLC [US]

US_2019209777_A1

Resumen de: WO2019136400A2

Safe and effective exercise poses a specific set of challenges for subjects diagnosed with diabetes. These challenges include the coordination of exercise with blood glucose monitoring and insulin administration. Failure to coordinate these factors effectively can lead to various pathologies related to aberrant blood glucose levels. Presented herein are methods, systems, algorithms, computer program products, web portals, real-time live instruction, and computer-executable code for exercise guidance and instruction specific to diabetes relief and management. The systems as disclosed herein can help ameliorate, slow, or reduce a likelihood of developing a diabetic condition.

traducir

SYSTEMS AND METHODS FOR INTERACTIVE EXERCISE THERAPY

NºPublicación: US2019209777A1 11/07/2019

Solicitante:

FITSCRIPT LLC [US]

WO_2019136400_A2

Resumen de: US2019209777A1

Safe and effective exercise poses a specific set of challenges for subjects diagnosed with diabetes. These challenges include the coordination of exercise with blood glucose monitoring and insulin administration. Failure to coordinate these factors effectively can lead to various pathologies related to aberrant blood glucose levels. Presented herein are methods, systems, algorithms, computer program products, web portals, real-time live instruction, and computer-executable code for exercise guidance and instruction specific to diabetes relief and management. The systems as disclosed herein can help ameliorate, slow, or reduce a likelihood of developing a diabetic condition.

traducir

CLOSED-LOOP CONTROL OF INSULIN INFUSION AND SYSTEM FOR MEASURING AUTONOMIC NERVOUS SYSTEM MODULATION

NºPublicación: US2019209776A1 11/07/2019

Solicitante:

MEDICUS ENG APS [DK]

US_2017368258_A1

Resumen de: US2019209776A1

Disclosed herein are devices, methods and systems for monitoring and detection of adverse events in a subject. In an embodiment, an insulin delivery device includes an insulin injection device in communication with a controller for controlling the insulin injection device. The controller is configured to receive a heart signal from one or more heart sensors, and a blood glucose signal from one or more blood glucose sensors. The controller is further configured to analyze changes in the heart rhythm of the subject based on the heart signal and determine, based on the changes in the heart rhythm and the blood glucose signal, whether the subject is and/or will be experiencing an adverse event. Upon determination that the subject is or will be experiencing an adverse event, the controller determines one or more parameters of delivery of insulin to be delivered to the subject. Finally, the controller is configured to control the injection device to deliver insulin to the subject in accordance with the determined one or more parameters of delivery.

traducir

SYSTEMS AND METHODS FOR REPLACING SIGNAL ARTIFACTS IN A GLUCOSE SENSOR DATA STREAM

NºPublicación: US2019209095A1 11/07/2019

Solicitante:

DEXCOM INC [US]

US_2018279959_A1

Resumen de: US2019209095A1

Systems and methods for minimizing or eliminating transient non-glucose related signal noise due to non-glucose rate limiting phenomenon such as interfering species, ischemia, pH changes, temperatures changes, known or unknown sources of mechanical, electrical and/or biochemical noise, and the like. The system monitors a data stream from a glucose sensor and detects signal artifacts that have higher amplitude than electronic or diffusion-related system noise. The system processes some or the entire data stream continually or intermittently based at least in part on whether the signal artifact event has occurred.

traducir

INTEGRATED MEDICAMENT DELIVERY DEVICE FOR USE WITH CONTINUOUS ANALYTE SENSOR

NºPublicación: US2019209009A1 11/07/2019

Solicitante:

DEXCOM INC [US]

US_2014288494_A1

Resumen de: US2019209009A1

An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

traducir

TIME-VARYING KINETIC MODELING OF HIGH TEMPORAL-RESOLUTION DYNAMIC PET DATA FOR MULTIPARAMETRIC IMAGING

NºPublicación: WO2019136469A1 11/07/2019

Solicitante:

UNIV CALIFORNIA [US]

Resumen de: WO2019136469A1

Systems and methods are disclosed for quantifying blood flow using time-varying kinetic modeling of high temporal-resolution dynamic positron emission tomography (PET) data. A single tracer is introduced into the body. A first set of images is acquired, via PET, of at least a portion of the body at a plurality of predetermined time intervals. Based on the first set of images, an intensity of the tracer in the at least the portion of the body is determined as a function of time. The intensity of the tracer as a function of time is modeled using a time-varying kinetic model. Based on the model, the blood flow through the at least the portion of the body is quantified. Additional images may be acquired and used to quantify additional parameter(s), such as glucose metabolism, amyloid load, etc., with the single tracer.

traducir

APPARATUS AND METHODS FOR ANALYTE SENSOR MISMATCH CORRECTION

NºPublicación: WO2019135988A1 11/07/2019

Solicitante:

GLYSENS INCORPORATED [US]

US_2019212323_A1

Resumen de: WO2019135988A1

Apparatus and methods for response modeling and correction of signals associated with a parameter sensor. In one exemplary embodiment, the parameter sensor is configured to measure a physiologic analyte of a living being (e.g., blood glucose), and the apparatus and methods employ a mathematical transformation of two or more sensing elements (electrodes) of the sensor in order to compensate for temporal response differences or "mismatch." This compensation enables the calculated blood analyte level, which results from processing of the signals of the two or more sensing electrodes, to be more accurate than calculations made without such compensation. In one variant, the parameter signals are generated, and compensation processing conducted, autonomously via a common implanted sensor platform.

traducir

ESTIMATION OF INSULIN BASED ON REINFORCEMENT LEARNING

NºPublicación: US2019214124A1 11/07/2019

Solicitante:

UNIV BERN [CH]

WO_2018011766_A1

Resumen de: US2019214124A1

The optimal insulin to be delivered by an insulin infusion pump is determined by using a reinforcement learning algorithm aiming to the personalized glucose regulation. The algorithm optimizes the daily basal insulin rate and insulin: carbohydrate ratio for each patient, on the basis of his/her measured glucose profile. The proposed algorithm is able to learn in real-time patient-specific characteristics captured in the daily glucose profile and provide individualised insulin treatment. An automatic and personalised tuning method contributes in the optimisation of the algorithm's performance.

traducir

BLOOD GLUCOSE MEASUREMENT DEVICE

NºPublicación: WO2019135478A1 11/07/2019

Solicitante:

SAMSUNG ELECTRONICS CO LTD [KR]

Resumen de: WO2019135478A1

A blood glucose measurement device is disclosed. The present blood glucose measurement device comprises: a substrate; a first resonance sensor and a second resonance sensor arranged on the substrate; and a shield layer arranged below the second resonance sensor with respect to the direction from the second resonance sensor toward a subject.

traducir

ENCAPSULATION OF PANCREATIC CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS

NºPublicación: US2019201582A1 04/07/2019

Solicitante:

VIACYTE INC [US]

JP_2018188484_A

Resumen de: US2019201582A1

The present invention relates to methods for encapsulating pancreatic progenitors in a biocompatible semi-permeable encapsulating device. The present invention also relates to production of human insulin in a mammal in response to glucose stimulation.

traducir

SYSTEMS AND METHODS FOR PREDICTION OF GLYCEMIA AND DECISIONS SUPPORT

NºPublicación: WO2019129857A1 04/07/2019

Solicitante:

HILLO AI [FR]

Resumen de: WO2019129857A1

Method for predicting glycemia of a patient including the steps of: Retrieving a data set (2) of dated glycemia measured up to the time t on the patient; Retrieving a quantity of insulin (5) injected in the patient; Retrieving a quantity of glucose (6) ingested by the patient; Generating, by a pharmacokinetic pre-processing device (20), an insulin blood concentration signal (21) and a carbs rate of appearance signal (22), from the glycemia data set (2), the quantities of injected insulin (5) and ingested glucose (6), Predicting by at least one Neural Network at least one glycemia (41) at prediction time t+Δΐ from the glycemia data (2) and from the signals generated (21) (22), the neural network being a Recurrent Neural Network able to keep in memory at each iteration information from any previous iteration.

traducir

WEARABLE DIAGNOSTIC DEVICE

NºPublicación: WO2019132915A1 04/07/2019

Solicitante:

SAYANI SALEEM [US]
MUQEET MUHAMMAD ABDUL [PK]
AHMED HAFIZ IMTIAZ [PK]

Resumen de: WO2019132915A1

A wearable diagnostic device worn on a user's body that can provide various types of health-related information to the user is described. The wearable diagnostic device can provide real-time, non-invasive, accurate, and continuous data regarding a user's heart rate, hemoglobin level, body temperature, oxygen level, glucose level, and blood pressure. In some implementations, the wearable diagnostic device may also provide electrocardiogram (EKG) data or detection of Parkinson's symptoms, such as the involuntary movement of a user's hand. A user may configure the wearable diagnostic device to provide information on one, multiple, or all of the health-related information noted above.

traducir

Systems and methods for providing sensitive and specific alarms

NºPublicación: AU2019204190A1 04/07/2019

Solicitante:

DEXCOM INC

CN_109480861_A

Resumen de: AU2019204190A1

Systems and methods for providing sensitive and specific alarms indicative of glycemic condition are provided herein. In an embodiment, a method of processing sensor data by a continuous analyte sensor includes: evaluating sensor data using a first function to determine whether a real time glucose value meets a first threshold; evaluating sensor data using a second function to determine whether a predicted glucose value meets a second threshold; activating a hypoglycemic indicator if either the first threshold is met or if the second threshold is predicted to be met; and providing an output based on the activated hypoglycemic indicator. The system (100) can include a continuous analyte sensor system (8), sensor electronics (12), a continuous analyte sensor (10), and other devices and/or sensors such as medicament delivery pump (2) and glucose meter (4) that can couple with one or more devices (14, 16, 18, and/or 20). < 0 n 0 000u 10 IJ LJ M C)L C C/) 00 D. <~~~~ >-0 u0 Z / L0> C- C z 2 ' LuJ CD LL <%

traducir

Method and Apparatus for Light-Weight, Non-Invasive, Point of Care Diabetes Screening Device

Nº publicación: US2019200904A1 04/07/2019

Solicitante:

GUPTA RIJUL [US]

WO_2018217765_A1

Resumen de: US2019200904A1

A multi-channel measurement device for measuring properties of human tissue, may comprise a microcontroller and first and second source/sensor complexes. The first source/sensor complex may include a first housing having a first measurement portion, a first light sensor coupled to the microcontroller and exposed to the first measurement portion, and a first plurality of light sources coupled to the microcontroller and exposed to the first measurement portion. The second source/sensor complex may include a second housing having a second measurement portion, a second light sensor coupled to the microcontroller and exposed to the second measurement portion, and a second plurality of light sources coupled to the microcontroller and exposed to the second measurement portion. The first and second source/sensor complexes are coupled to each other such that the first measurement portion is opposite the second measurement portion and human tissue may be placed between the the first and second measurement portions. The microprocessor is configured with instructions stored in non-volatile memory to individually activate each of the light sources of the first and second pluralities of light sources and to record light intensity detected by the first and second light sources while an individual light source is activated. Each combination of an individually activated light source and one of the first and second light sensors provides a distinct measurement channel for measuring the absorpt

traducir

Página1 de 6 nextPage por página

punteroimgVolver